Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Travelers Companies Stock (TRV) Opinions on Barclays Downgrade

None

Barclays downgrade: Analysts recently downgraded Travelers to Underweight and reduced the price target citing softening pricing and slowing growth in the property and casualty insurance space. This development has prompted extensive commentary on mounting margin pressures across the sector. Observers note that earnings upside appears increasingly limited in the current environment.

Trading patterns: Market participants describe a clear trading range with defined support and resistance levels that could dictate near-term moves. Some highlight the potential for a correction after recent advances while others discuss artificial intelligence applications in risk management and underwriting. The stock featured among notable decliners in recent trading sessions amid the news flow.

Broader views: Conversation centers on how these analyst actions reflect evolving dynamics in insurance markets. Participants weigh the implications for operational efficiency against industry-wide headwinds. The overall tone remains measured as investors assess the path forward.

Note: This discussion summary was generated from an AI condensation of post data.

Travelers Companies Insider Trading Activity

TRV Insider Trades

Travelers Companies insiders have traded $TRV stock on the open market 35 times in the past 6 months. Of those trades, 0 have been purchases and 35 have been sales.

Here’s a breakdown of recent trading of $TRV stock by insiders over the last 6 months:

  • ALAN D SCHNITZER (Chairman and CEO) has made 0 purchases and 3 sales selling 55,733 shares for an estimated $16,424,516.
  • MICHAEL FREDERICK KLEIN (EVP & President, Personal Ins.) has made 0 purchases and 6 sales selling 30,000 shares for an estimated $9,126,019.
  • JEFFREY P. KLENK (EVP & Pres., Bond & Spec. Ins.) has made 0 purchases and 2 sales selling 23,125 shares for an estimated $6,632,142.
  • MARIA OLIVO (EVP, ERM & Chief Risk Officer) has made 0 purchases and 2 sales selling 20,800 shares for an estimated $6,316,420.
  • WILLIAM H HEYMAN (Vice Chairman) has made 0 purchases and 9 sales selling 13,557 shares for an estimated $4,130,425.
  • GREGORY C TOCZYDLOWSKI (EVP & President, Business Ins.) sold 12,199 shares for an estimated $3,656,983
  • AVROHOM J. KESS (Vice Chmn. & Chief Legal Off.) has made 0 purchases and 2 sales selling 11,491 shares for an estimated $3,508,540.
  • ANDY F BESSETTE (EVP and Chief Admin Officer) has made 0 purchases and 4 sales selling 10,255 shares for an estimated $3,096,933.
  • DANIEL S. FREY (EVP & Chief Financial Officer) sold 8,000 shares for an estimated $2,395,960
  • MOJGAN M LEFEBVRE (EVP & Chief Tech & Ops Officer) sold 5,826 shares for an estimated $1,737,815
  • PAUL E. MUNSON (SVP & Corp. Controller) has made 0 purchases and 2 sales selling 3,727 shares for an estimated $1,140,611.
  • DIANE KURTZMAN (EVP & Chief HR Officer) has made 0 purchases and 2 sales selling 2,867 shares for an estimated $869,980.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

Travelers Companies Revenue

TRV Quarterly Revenue

Travelers Companies had revenues of $11.9B in Q1 2026. This is an increase of 0.97% from the same period in the prior year.

You can track TRV financials on Quiver Quantitative's TRV stock page.

You can access data on TRV stock through the Quiver Quantitative API.

Travelers Companies Congressional Stock Trading

Members of Congress have traded $TRV stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $TRV stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

Travelers Companies Hedge Fund Activity

We have seen 794 institutional investors add shares of Travelers Companies stock to their portfolio, and 807 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • FMR LLC removed 835,366 shares (-6.5%) from their portfolio in Q1 2026, for an estimated $243,659,554
  • AQR CAPITAL MANAGEMENT LLC added 748,066 shares (+43.7%) to their portfolio in Q1 2026, for an estimated $218,195,890
  • BLACKROCK, INC. removed 671,358 shares (-3.0%) from their portfolio in Q1 2026, for an estimated $195,821,701
  • JPMORGAN CHASE & CO removed 577,610 shares (-7.5%) from their portfolio in Q4 2025, for an estimated $167,541,556
  • NORGES BANK removed 552,565 shares (-18.1%) from their portfolio in Q4 2025, for an estimated $160,277,003
  • CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM removed 417,686 shares (-39.6%) from their portfolio in Q1 2026, for an estimated $121,830,652
  • AMUNDI added 373,061 shares (+36.6%) to their portfolio in Q1 2026, for an estimated $108,814,432

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Travelers Companies Analyst Ratings

Wall Street analysts have issued reports on $TRV in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Cantor Fitzgerald issued a "Overweight" rating on 02/02/2026
  • Keefe, Bruyette & Woods issued a "Outperform" rating on 01/23/2026

To track analyst ratings and price targets for Travelers Companies, check out Quiver Quantitative's $TRV forecast page.

Travelers Companies Price Targets

Multiple analysts have issued price targets for $TRV recently. We have seen 12 analysts offer price targets for $TRV in the last 6 months, with a median target of $317.0.

Here are some recent targets:

  • Alex Scott from Barclays set a target price of $295.0 on 06/12/2026
  • Paul Newsome from Piper Sandler set a target price of $340.0 on 05/26/2026
  • Jimmy Bhullar from JP Morgan set a target price of $322.0 on 05/26/2026
  • Meyer Shields from Keefe, Bruyette & Woods set a target price of $342.0 on 04/20/2026
  • Michael Zaremski from BMO Capital set a target price of $314.0 on 04/20/2026
  • David Motemaden from Evercore ISI Group set a target price of $321.0 on 04/17/2026
  • Joshua Shanker from B of A Securities set a target price of $257.0 on 04/14/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles